Rubella screening and vaccination follow-up by a hospital employee health office.
The data in the present study indicate two major points. One is that the facility under question has an unusually low rate of rubella susceptibility. The other is that the referral of seronegative employees to an outside agency for vaccination (in this case the local CHD) is not nearly as effective, with respect to employee compliance, as an in-house program. Despite the added immediate cost to the hospital for administering the vaccine, the possibility of employee-to-patient transmission of the rubella virus poses the threat of a much higher future cost. It is suggested that facilities that do not currently have an in-house rubella vaccination program should reevaluate the effectiveness of their programs.
D000328:Adult; D000914:Antibodies, Viral / Q000032:analysis; D003428:Cross Infection / Q000517:prevention & control*; D005260:Female; D006801:Humans; D008297:Male; D009786:Occupational Health Services; D010564:Personnel, Hospital; D011247:Pregnancy; D012409:Rubella / Q000517:prevention & control*; D012411:Rubella Vaccine / Q000627:therapeutic use*; D012412:Rubella virus / Q000276:immunology
D000914:Antibodies, Viral; D012411:Rubella Vaccine